Xvivo Perfusion AB
XVIVO.ST
25,78 €
Share price
-1.77%
Change (1 day)
12.52%
Change (1 year)
Categories
EPS for Xvivo Perfusion AB (XVIVO.ST)
EPS in 2024 (TTM): 0,13 €
According to Xvivo Perfusion AB's latest financial reports the company's current EPS (TTM) is 0,13 €. In 2023 the company made an earnings per share (EPS) of 0,28 € an increase over its 2022 EPS that were of 0,05409 €.
EPS history for Xvivo Perfusion AB from 2012 to 2024
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2024 (TTM) | 0,13 € | -52.5% |
| 2023 | 0,28 € | 411.27% |
| 2022 | 0,05409 € | 92.65% |
| 2021 | 0,02807 € | -115.74% |
| 2020 | -0,18 € | -1066.98% |
| 2019 | 0,01844 € | -61.96% |
| 2018 | 0,04849 € | 74.89% |
| 2017 | 0,02772 € | 296.52% |
| 2016 | 0,006992 € | -72.99% |
| 2015 | 0,02589 € | -11.5% |
| 2014 | 0,02925 € | -49.57% |
| 2013 | 0,05801 € | -1139.45% |
| 2012 | -0,005581 € |